Currently Viewing:
Association of Community Cancer Centers Annual Meeting
Pamela Tobias Discusses Handling Data in EHRs and the Future of Data in Clinical Practices
June 24, 2018
James Grayson Explains How Healthcare Can Learn Burnout Prevention Tactics From Air Traffic Control
June 22, 2018
Thomas Asfeldt on the Benefits to Patients and Practices of Integrated Cancer Care Teams
June 17, 2018
Clara Lambert: Health-Related Financial Challenges Go Beyond Insurance Coverage
June 12, 2018
Barbara Tofani Explains the Understanding Needed to Set Up a Care Coordination Model
June 10, 2018
Dr Kathleen Blake: Successful Clinician Burnout Programs Address Health System Problems
June 09, 2018
Dr Yousuf Zafar: Predicting Financial Hardship Is Challenging
June 08, 2018
Thomas Asfeldt: Technology Has Been Fantastic for Integrated Care
June 07, 2018
Pamela Tobias Outlines Using Data in EHRs and Data That Go Underutilized
June 06, 2018
Currently Reading
Dr James Hamrick Discusses the Importance of Real-World Data
June 05, 2018
Barbara Tofani: Asking 2 Simple Questions Can Lead to Truly Patient-Centered Care
June 01, 2018
Clara Lambert on Screening Patients for Financial Distress
May 31, 2018
Dr Kathleen Blake Identifies the Biggest Stressors Causing Burnout
May 31, 2018
Dr Yousuf Zafar Explains How to Broach the Topic of Cost With Patients
May 30, 2018
Dr Charles Saunders: Practices Don't Integrate Technology Well
May 29, 2018
Thomas Asfeldt Outlines Best Practices for Creating an Integrated Team and Communicating
May 28, 2018
Dr James Hamrick Highlights How Technology Eases Burdens on Research Staff
May 25, 2018
James Grayson: Burnout Continues to Get Worse Among Physicians and Presents in Different Ways
May 24, 2018
Clara Lambert Discusses the Role of Financial Navigators and Explaining Insurance Coverage
May 23, 2018
Barbara Tofani Outlines Best Practices and Mistakes of Care Coordination
May 22, 2018
Dr Kathleen Blake Outlines How Burnout Affects Specialties Differently
May 21, 2018
Dr Charles Saunders Highlights Data Collection Challenges
May 18, 2018
Dr Mark Soberman Discusses Integrated Care Teams in Oncology
May 16, 2018
Pamela Tobias Discusses Pulling Data from EHRs to Improve Processes
May 15, 2018

Dr James Hamrick Discusses the Importance of Real-World Data

James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health, discusses the importance of real-world data and how it augments traditional clinical trial data.


James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health, discusses the importance of real-world data and how it augments traditional clinical trial data.

Transcript

What is the importance of real-world data and how do we ensure greater use of it?

Real-world data is just an enormous opportunity. So, real-world data, real-world evidence, and pragmatic clinical trials are never going to replace traditional clinical trials—they shouldn’t. They should augment them. And, so, they can make us design smarter, traditional trials.

There’s a virtuous cycle of real-world data generation, using that to generate evidence that makes us design smarter protocols for traditional trials, and then that cycles through to clinical care. So, if you think about that cycle, if you can understand, for instance, what’s happening in standard of care out in the community, and you’re writing a protocol, that’s going to inform your control arm and it’s going to make sure that the traditional trial you run gives you the relevant answers that you need and that the patients need and that the doctors need to really roll out the new treatment out into the real world.

Now, to make real-world data useful, it has to be exceptionally, scientifically rigorous. So, one thing that we’re doing at Flatiron, is we’re doing a lot of time partnering with the FDA, working on publications to be released in to the peer-reviewed literature, because we want to be very transparent on our methods and make sure that they’re completely scientifically rigorous, and that they’re vetted in the peer-review format by the scientific community. Because there’s an enormous amount of potential learning that we can have from the data that’s generated at the point of care, but you have to be very careful, so you don’t draw spurious conclusions and so that it really helps us understand what is happening in the field.

As we move toward more value-based care models, how does real-world data have more importance?

Real-world data really does have an important place in the value-based care world, because it’s going to help us understand things that we never understood before. We’ve extrapolated from traditional clinical trials what we expect to happen.

You can imagine a world where we really have a real-time snapshot of what’s going on in cancer care in the United States, and we can use that for things like understanding how reimbursement should work, how incentives should work, in order to get us all to the goals that we want, which is super high-quality care based on outcomes that patients care about, that’s at a good value. So, that’s not breaking the bank. And that if we’re going to pay a lot, we’re getting excellent results.

I think real-world data and real-world evidence, if it’s high-quality and rigorous, is really going to enable us to be smarter about how we deliver high-value care.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!